Ra Pharmaceuticals, Inc. announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference.
A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180531005033/en/
Contacts
Ra Pharmaceuticals, Inc.
Investors:
Jennifer Robinson, 617-674-9873
jrobinson@rapharma.com
or
Media:
Argot Partners
David Rosen, 212-600-1902
david.rosen@argotpartners.com
Source: Ra Pharmaceuticals, Inc.
